1. Causal associations of autoimmune thyroiditis and papillary thyroid carcinoma: mRNA expression of selected nuclear receptors and other molecular targets
   Dana Macejova et al, 2019, Oncology Letters CrossRef
2. Secreted Pyruvate Kinase M2 Promotes Lung Cancer Metastasis through Activating the Integrin Beta1/FAK Signaling Pathway
   Caihong Wang et al, 2020, Cell Reports CrossRef
3. Bioinformatics analysis of microarray data to identify the candidate biomarkers of lung adenocarcinoma
   Tingting Guo et al, 2019, PeerJ CrossRef
4. Potentially functional genetic variants in the complement‐related immunity gene‐set are associated with non‐small cell lung cancer survival
   Danwen Qian et al, 2019, International Journal of Cancer CrossRef
5. Activation of the Complement System in Patients with Cancer Cachexia
   Min Deng et al, 2021, Cancers CrossRef
6. Prevention effects of Schisandra polysaccharide on radiation-induced immune system dysfunction
   Lian-Mei Zhao et al, 2015, International Journal of Biological Macromolecules CrossRef
7. Complement in Tumourigenesis and the Response to Cancer Therapy
   Rebecca M. O’Brien et al, 2021, Cancers CrossRef
8. N-Glycan and Glycopeptide Serum Biomarkers in Philippine Lung Cancer Patients Identified Using Liquid Chromatography–Tandem Mass Spectrometry
   Michael Russelle S. Alvarez et al, 2022, ACS Omega CrossRef
9. Targeting the Complement Pathway as a Therapeutic Strategy in Lung Cancer
   Emily K. Kleczko et al, 2019, Frontiers in Immunology CrossRef
10. Complement in cancer: untangling an intricate relationship
    Edimara S. Reis et al, 2018, Nature Reviews Immunology CrossRef
11. Recruitment of IL‐1β‐producing intermediate monocytes enhanced by C5a contributes to the development of malignant pleural effusion
    Lisha Luo et al, 2022, Thoracic Cancer CrossRef
12. The complement cascade in lung injury and disease
    M. G. Detsika et al, 2024, Respiratory Research CrossRef
13. Prognostic Value of Complement Component 2 and Its Correlation with Immune Infiltrates in Hepatocellular Carcinoma
    Gang Ning et al, 2020, BioMed Research International CrossRef
14. The role of the complement system in cancer
    Vahid Afshar-Kharghan, 2017, Journal of Clinical Investigation CrossRef
15. Elevated expression of complement factor I in lung cancer cells associates with shorter survival–Potentially via non-canonical mechanism
    Anna Felberg et al, 2024, Translational Research CrossRef
16. Mass spectrometry‐based secretome analysis of non‐small cell lung cancer cell lines
    Konstanze Bosse et al, 2016, PROTEOMICS CrossRef
17. Complement Component C3 and Complement Factor B Promote Growth of Cutaneous Squamous Cell Carcinoma
    Pilvi Riihilä et al, 2017, The American Journal of Pathology CrossRef
18. Value of immune factors for monitoring risk of lung cancer in patients with interstitial lung disease
    Ning Li et al, 2019, Journal of International Medical Research CrossRef
19. Identification of protein changes in the blood plasma of lung cancer patients subjected to chemotherapy using a 2D-DIGE approach
    Andrzej Ciereszko et al, 2019, PLOS ONE CrossRef
20. Key genes and pathways predicted in papillary thyroid carcinoma based on bioinformatics analysis
    J. Yu et al, 2016, Journal of Endocrinological Investigation CrossRef
21. Silencing of carbonic anhydrase I enhances the malignant potential of exosomes secreted by prostatic tumour cells
    Radivojka Bánová Vulić et al, 2019, Journal of Cellular and Molecular Medicine CrossRef
22. Innate immune mediators in cancer: between defense and resistance
    Pedro Berraondo et al, 2016, Immunological Reviews CrossRef
23. The Effect of Exercise on Gene Expression and Signaling in Mouse Melanoma Tumors
    ZHI XIA et al, 2020, Medicine & Science in Sports & Exercise CrossRef
24. A Comprehensive Investigation toward the Indicative Proteins of Bladder Cancer in Urine: From Surveying Cell Secretomes to Verifying Urine Proteins
    Jiao Guo et al, 2016, Journal of Proteome Research CrossRef
25. Proteomic level changes associated with S3I201 treated U87 glioma cells
    Rekha Jain et al, 2017, Journal of Proteomics CrossRef
26. The molecular mechanisms of apoptosis accompanied with the epigenetic regulation of the NY-ESO-1 antigen in non-small lung cancer cells treated with decitabine (5-aza-CdR)
    Varghese P. Inchakalody et al, 2023, European Journal of Pharmacology CrossRef